CHAPTER 46 CEREBRAL VENOUS THROMBOSIS
Cerebral vein and sinus thrombosis (CVST) is a rare event in comparison with arterial stroke, accounting for less than 1% of all strokes. CVST occurs in all age groups, peaking in incidence among neonates and young adults. Clinical diagnosis is difficult, because of the wide spectrum of clinical symptoms of CVST. The achievements of neuroimaging since the 1970s have been fundamental for diagnosing and treating CVST and for a better understanding of its pathogenesis. Early diagnosis of CVST is crucial, because therapy, based mainly on anticoagulation, reduces the risk of fatal outcome and severe disability.1,2
ANATOMY OF THE INTRACRANIAL VENOUS SYSTEM
Cortical Cerebral Veins
Deep Cerebral Veins
Posterior Fossa Veins
The venous drainage of the posterior fossa is highly variable. Four main systems can be outlined:
Dural Sinuses
The dural sinuses are situated between the leaves of the falx and the tentorium and are triangular in section. They drain blood from the cortex, the meninges, and the scalp (through the calvarian veins) and deliver it to the internal jugular veins. They are connected with the extracranial veins in the scalp by the emissary veins. This may explain dural involvement after cutaneous contusions or infections (Fig. 46-1).
Venous Anastomoses
The intracranial venous system has no valves and therefore allows reversals of the blood flow direction, following pressure gradients. The most important vessels of this system are (1) the great anastomotic vein of Trolard that runs from the sylvian fissure to the SSS, thus forming an anastomosis between the SSS and the petrosal sinuses, and (2) the little anastomotic vein of Labbé, which connects the superficial sylvian vein with the transverse sinus or connects the SSS with the transverse sinus (depending on interindividual variability). There are also other, less important links, such as those between the little cortical veins and the adjacent sinuses or those between the basal vein of Rosenthal and the cortical veins. Transcerebral veins are virtual vessels that, when necessary, connect superficial and deep veins, crossing the cerebral parenchyma. The dural sinuses also communicate with the meningeal, diploic, and calvarian veins through the emissary veins.1–5
EPIDEMIOLOGY
CVST may manifest with such a wide spectrum of clinical signs and symptoms that it goes unrecognized in quite a few patients. It follows that epidemiological studies are difficult to perform. On the basis of retrospective trials, CVST accounts for about 0.1% to 9% (mean, about 1%) of all deaths for stroke, with great geographic and ethnic variabilities.1,2,6–8 In industrialized countries, the incidence of CVST is estimated between 1.5 and 2.5 cases per 100,000 per year.6 Although these numbers, based on CT scan or magnetic resonance imaging (MRI) findings, are remarkably higher than those observed before the neuroimaging era, they still account for only patients who present with the more severe consequences of CVST: namely, hemorrhagic or ischemic venous strokes. As the frequency of venous stroke ranges from 30% to 80% of all cases, the prevalence of patients who develop symptoms related to intracranial hypertension might be considerably higher.6,9–12
In a multicenter prospective observational study, 624 patients with CVST were enrolled. Female gender was prevalent (74.5%); the mean age was 39 years. Patients were predominantly white (79.2% versus 9.3% Hispanic, 5% black, 3.4% Asian, and 3.1% other races). Ischemic venous infarction was present in 46.5% patients, and hemorrhagic lesions were detected in 39.3% patients. Ischemic and hemorrhagic infarcts coexisted in some patients; the cumulative rate of parenchymal lesions at neuroimaging was 62.9%. The SSS was the most frequently involved (62%), followed by the left lateral sinus (44.7%), the right transverse sinus (41.2%), the straight sinus (18%), the choroidal vein (17.1%), and the jugular veins (11.9%). The deep venous system was involved in 10.9% of patients, and the cavernous sinuses in 1.3%. A posterior fossa vein thrombosis was reported in only 0.3%.13
In one study, researchers have investigated the distribution of risk factors and clinical features of CVST among white and African-Brazilian patients. The female/male ratio was higher among the African-Brazilian patients than among the white patients (4.75 versus 1.36), whereas the mean ages were similar. African-Brazilian patients had higher rates of focal deficits (60.8% versus 46.1%) and decreased consciousness (47.8% versus 27%); however, these differences were not significant.7
A high incidence of CVST in young women, especially during pregnancy and the puerperium, has been reported in several studies.6,11,12 As a matter of fact, estimates of CVST associated with pregnancy and the puerperium range from 2 to 60 per 100,000 deliveries in western Europe and North America and from 200 to 500 per 100,000 in India.1,2 The use of oral contraceptives appears to be a risk factor for CVST.1,2,6,10–13
PATHOPHYSIOLOGY
The causal factors leading to CVST are essentially four: (1) prothrombotic state; (2) venous stasis; (3) direct involvement of the venous wall; and (4) abnormal blood viscosity.14 Symptoms of sinovenous occlusion may arise directly from the primary or underlying process, venous obstruction, vascular inflammation, or secondary complications. Venous obstruction causes a rise of venous and parenchymal pressure in its competence territory, which leads to venous distension and edema. Many of the clinical consequences of CVST arise from brain swelling and increased intracranial pressure caused both by venous engorgement and by decreased cerebrospinal fluid absorption secondary to venous hypertension. Furthermore, in the majority of cases, thrombosis involves multiple dural sinuses or both sinuses and veins.1,2,13,15
Experimental studies have contributed to a better definition of the pathological features of CVST. A subacute occlusion of SSS provokes clinical manifestations only when the occlusion spreads to cortical or bridging veins.16–20 SSS occlusion is usually associated with brain swelling, an increase in intracranial pressure, and diffuse cellular damage.16–21 On the other hand, occlusion of bridging and cortical veins produces a localized well-shaped venous infarction, with both ischemic and hemorrhagic features, surrounded by brain swelling and edema.19–23 In cats, the ligature of SSS provokes a stroke only when located after the confluence between this sinus and the rolandic vein, because the anterior third of the sinus is well compensated by collateral vessels. What is remarkable is that ischemic/hemorrhagic lesions are absent at 2 hours but present at 24 hours; this demonstrates that the acute occlusion of a dural sinus, at least in experimental conditions, is related not to an acute infarction but only to a subacute one.19 This observation could also apply to humans, inasmuch as the majority of patients with dural sinus involvement exhibit a subacute onset of the CVST signs and symptoms. Also remarkable is that neither the site nor the extent of a sinus occlusion is indicative of the final site and size of the corresponding ischemic lesion. On the contrary: The thrombosis of a cortical vein produces a definite area of infarction in the gray and superficial white matter. As a consequence, patients with cortical and deep vein thrombosis show the worst clinical outcome,22 because the deep vein thrombosis produces a widespread lesion that involves the thalamus, the deep white matter, and the upper parts of the brainstem.1,2,24
DIAGNOSIS AND CLINICAL FEATURES
Headache is the most frequent presenting symptom and the most common complaint (75% of cases).1,2,12,25 The headache is usually diffuse and progressive, with no typical clinical characteristics or temporal profile. In the 2004 International Classification of Headache Syndromes, headache associated with CVST is classified as follows: (1) any new headache, with or without neurological signs, that fulfills the second and third criteria; (2) headache with neuroimaging evidence of CVST; (3) headache (and neurological signs, if present) that develops in close temporal relation to CVST.26
Intracranial Hypertension Syndrome
Headache is the most common clinical symptom of IHS, reported in 75% to 95% of patients.6 It represents the inaugural symptom in 70% to 75% of cases and is often the unique clinical manifestation of IHS.6–27 The headache may be any grade of severity, diffuse or localized, and persistent or intermittent. The onset is usually subacute (2 to 30 days) but can also be acute (>2 days) or chronic (>30 days).1,2 Attacks may mimic migraine or may be interpreted as a subarachnoid hemorrhage manifesting as a thunderclap-type headache, with instantaneous onset and coming on very quickly.27 Papilledema is observed in about 50% of affected patients.11 Only 20% to 40% of patients have the complete syndrome of isolated IHS with headache, nausea, vomiting, papilledema, transient visual obscurations, and eventually cranial nerve VI palsy. The involvement of other cranial nerves is very rare.6 IHS resulting from CVST should be differentiated by the idiopathic intracranial hypertension or pseudotumor cerebri, with a complete neuroradiological workup. IHS is more frequently caused by the occlusion of the dural sinuses, particularly the SSS.1,2,27
Stroke-Related Syndrome
This syndrome is typically related to the occurrence of a venous infarction that can be both ischemic and hemorrhagic. In the majority of cases, the pattern is represented by multiple small intraparenchymal hemorrhages, surrounded either by normal parenchyma or by ischemic areas. Its clinical features are ill-defined and differ from those of an arterial stroke, which is more sharply outlined and wedge-shaped. The abundance of collateral vessels and anastomosis of the venous circulation, in comparison with the arterial circulation, is responsible for the lack of topographic localization of the lesions. Focal neurological signs (sensory and motor deficits, speech disturbances, hemianopia) are present in 40% to 60% of all cases.6 Headache, vomiting, and ataxia with acute onset are the most frequent symptoms in patients with cerebellar vein thrombosis, which is always associated with a concomitant effect on the lateral sagittal sinus and SSS.6
Encephalopathic Syndrome
This condition is the least frequent manifestation of CVST but also the most severe. It is typically related to the involvement of the deep venous system, with diffuse damage of the white matter, basal ganglia, thalamus, and mesencephalon. Parenchymal damage may be related to necrosis, hemorrhages, and brain swelling.1,2,28 The clinical syndrome is characterized by generalized seizures, psychiatric disturbances, confusion, and variable levels of consciousness, disorders of which range from stupor to coma.1,2,6,10,11,25 Major cognitive impairments are reported in only 15% to 19% of cases.6
Focal or generalized seizures are present in more than 40% of patients with CVST2 and may occur in every related clinical syndrome. During the puerperium, the incidence is even higher (76%).6,12 Among the focal forms, the jacksonian type is the most common and is characteristically associated with Todd’s postconvulsive paresis, which is rare in idiopathic epilepsy.6,12,29 Nonetheless, only a few cases progress to epilepsy.29
Cavernous sinus thrombosis provokes a peculiar neurological syndrome characterized by any combination of unilateral chemosis, proptosis, and eyelid edema (caused by inadequate ocular venous drainage from the ophthalmic vein), with diplopia resulting from the involvement of the oculomotor nerves. Myosis and ptosis may also be present as a result of involvement of the third cranial nerve, as may mydriasis, caused by the involvement of the pericarotic sympathetic plexus. Retro-orbital and/or frontotemporal pain and anesthesia in the territories of the first and second branches of the trigeminus may also be present, constituting the so-called painful ophthalmoplegia. In the case of slow occlusion of the sinus, the only clinical manifestation may be limited to the sixth nerve palsy accompanied with pain. The thrombosis may extend to the contralateral sinuses. The differential diagnosis should take into consideration other causes of painful ophthalmoplegia such as the Tolosa-Hunt syndrome, which is an idiopathic granulomatous inflammation of the dural wall of the cavernous sinuses; giant cells arteritis; sarcoidosis; local or general neoplasm; pseudotumor orbitae; and infectious thrombophlebitis caused by the propagation of a septic process from the face or neck into the cavernous sinuses.30
DIAGNOSTIC METHODS
Venous angiography was the first instrumental technique used to diagnose CVST. Today, its clinical use is limited to dubious cases because of its excellent sensitivity. Angiography shows venous thrombosis as an interruption of flow that may be differentiated by sinus aplasia by the presence of a tortuous collateral circulation, consisting of “corkscrew vessels.”1,2 These vessels cannot be visualized by any other technique, and thus angiography remains the most important diagnostic tool in these cases.31
CT scan is usually the first investigation performed in the emergency department6; thus, it plays an important role in differential diagnosis, allowing the clinician to rule out disorders that may mimic CVST, such as tumors, encephalitis, brain abscesses, and subarachnoid hemorrhage.32 However, CT scans may be normal in 25% to 30% of patients.6
On CT scan, CVST may show direct and indirect signs. Direct signs are as follows: